Center-Authored Papers

Filters: Author is Feuer, Eric J  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
Tsodikov A, Gulati R, Heijnsdijk EAM, Pinsky PF, Moss SM, Qiu S, de Carvalho TM, Hugosson J, Berg CD, Auvinen A et al..  2017.  Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.. Annals of internal medicine. Abstract
P
Etzioni R, Gulati R, Tsodikov A, Wever EM, Penson DF, Heijnsdijk EAM, Katcher J, Draisma G, Feuer EJ, de Koning HJ et al..  2012.  The prostate cancer conundrum revisited : Treatment changes and prostate cancer mortality declines.. Cancer. Abstract
Lansdorp-Vogelaar I, Gulati R, Mariotto AB, Schechter CB, de Carvalho TM, Knudsen AB, van Ravesteyn NT, Heijnsdijk EAM, Pabiniak C, van Ballegooijen M et al..  2014.  Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.. Annals of internal medicine. 161(2):104-12. Abstract
Holford TR, Levy DT, McKay LA, Clarke L, Racine B, Meza R, Land S, Jeon J, Feuer EJ.  2014.  Patterns of birth cohort-specific smoking histories, 1965-2009.. American journal of preventive medicine. 46(2):e31-7. Abstract
M
Habbema DJF, Wilt TJ, Etzioni R, Nelson HD, Schechter CB, Lawrence WF, Melnikow J, Kuntz KM, Owens DK, Feuer EJ.  2014.  Models in the development of clinical practice guidelines.. Annals of internal medicine. 161(11):812-8. Abstract
I
Moolgavkar SH, Holford TR, Levy DT, Kong CY, Foy M, Clarke L, Jeon J, Hazelton WD, Meza R, Schultz F et al..  2012.  Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000.. Journal of the National Cancer Institute. 104(7):541-8. Abstract
Han SS, Ten Haaf K, Hazelton WD, Munshi VN, Jeon J, Erdogan SA, Johanson C, McMahon PM, Meza R, Kong CY et al..  2017.  The impact of overdiagnosis on the selection of efficient lung cancer screening strategies.. International journal of cancer. Abstract
E
Kong CY, Kroep S, Curtius K, Hazelton WD, Jeon J, Meza R, Heberle C, Miller M, Choi SE, Lansdorp-Vogelaar I et al..  2014.  Exploring the Recent Trend in Esophageal Adenocarcinoma Incidence and Mortality Using Comparative Simulation Modeling.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
C
Gulati R, Feuer EJ, Etzioni R.  2016.  Conditions for Valid Empirical Estimates of Cancer Overdiagnosis in Randomized Trials and Population Studies.. American journal of epidemiology. 184(2):140-7. Abstract
McMahon PM, Meza R, Plevritis SK, Black WC, Tammemagi MC, Erdogan A, Ten Haaf K, Hazelton W, Holford TR, Jeon J et al..  2014.  Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the national lung screening trial using comparative modeling.. PloS one. 9(6):e99978. Abstract
Meza R, Ten Haaf K, Kong CY, Erdogan A, Black WC, Tammemagi MC, Choi SE, Jeon J, Han SS, Munshi V et al..  2014.  Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials.. Cancer. Abstract
B
de Koning HJ, Meza R, Plevritis SK, Ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, van Rosmalen J et al..  2013.  Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force.. Annals of internal medicine. Abstract